Pfizer : PFE

All Pfizer Articles

1465 Articles

Paul Ausick | Nov 4, 2015 at 4:01 PM EST

The 4 Stocks Held Down the DJIA on Wednesday

November 4, 2015: Markets opened higher on Wednesday following an in-line report on jobs from ADP and somewhat smaller-than-expected U.S.…

Lee Jackson | Nov 4, 2015 at 10:40 AM EST

UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped

Solid growth stocks that pay good dividends make sense, especially when they all pay higher dividends than the current 30-year…

Chris Lange | Nov 3, 2015 at 11:45 AM EST

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The health care sector may have sold off a fair amount since this past summer, but there is some M&A…

Paul Ausick | Nov 2, 2015 at 4:01 PM EST

The 4 Stocks Lifted the DJIA on Monday

November 2, 2015: Markets opened higher on Monday and added strength as the day drew to a close. Healthcare and…

Chris Lange | Oct 31, 2015 at 10:10 AM EDT

6 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, and some had serious falls.

Paul Ausick | Oct 30, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the Dow on Friday

October 30, 2015: Markets opened higher on Friday before falling into the red until the early afternoon. Financial stocks could…

Paul Ausick | Oct 29, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

ThinkstockOctober 29, 2015: Markets opened lower on Thursday after a GDP report that was a bit softer than expected and…

Jon C. Ogg | Oct 29, 2015 at 11:05 AM EDT

What a Combined Allergan and Pfizer Might Actually Look Like

Allergan has issued a press release that confirms some of the rumors floating in the market that it has been…

Jon C. Ogg | Oct 27, 2015 at 10:05 AM EDT

How Pfizer Stacks Up Against Merck on Earnings

Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Oct 26, 2015 at 3:25 PM EDT

What to Look For in Pfizer’s Earnings

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Lee Jackson | Oct 26, 2015 at 10:15 AM EDT

4 Merrill Lynch Top-Yielding Dividend Stocks to Buy for Q4

Most investors have had a rough 2015, and with the Nasdaq the only index that is up for the year…

Chris Lange | Oct 25, 2015 at 9:10 AM EDT

5 Dow Stocks Reporting Earnings This Week

24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average…

Lee Jackson | Oct 23, 2015 at 8:35 AM EDT

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and…

Paul Ausick | Oct 21, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Wednesday

ThinkstockOctober 21, 2015: Markets opened higher on Wednesday on the trail of gains in both Japan and Europe. Shanghai closed…

1 … 54 55 56 57 58 … 98

Pfizer : PFE

All Pfizer Articles

The 4 Stocks Held Down the DJIA on Wednesday

UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The 4 Stocks Lifted the DJIA on Monday

6 BioPharma Movers That Cannot Be Ignored

The 4 Stocks That Sank the Dow on Friday

The 4 Stocks That Weighed on the DJIA Thursday

What a Combined Allergan and Pfizer Might Actually Look Like

How Pfizer Stacks Up Against Merck on Earnings

Short Sellers Have Mixed Views on Major Pharma

What to Look For in Pfizer’s Earnings

4 Merrill Lynch Top-Yielding Dividend Stocks to Buy for Q4

5 Dow Stocks Reporting Earnings This Week

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

The 4 Stocks That Weighed on the DJIA Wednesday

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Which Drone Stock Will Dominate the Next War: AVAV, KTOS, or ONDS?

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Pfizer : PFE

All Pfizer Articles

The 4 Stocks Held Down the DJIA on Wednesday

UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The 4 Stocks Lifted the DJIA on Monday

6 BioPharma Movers That Cannot Be Ignored

The 4 Stocks That Sank the Dow on Friday

The 4 Stocks That Weighed on the DJIA Thursday

What a Combined Allergan and Pfizer Might Actually Look Like

How Pfizer Stacks Up Against Merck on Earnings

Short Sellers Have Mixed Views on Major Pharma

What to Look For in Pfizer’s Earnings

4 Merrill Lynch Top-Yielding Dividend Stocks to Buy for Q4

5 Dow Stocks Reporting Earnings This Week

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

The 4 Stocks That Weighed on the DJIA Wednesday

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Which Drone Stock Will Dominate the Next War: AVAV, KTOS, or ONDS?

Featured Reads

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes